The drugs discovery program is for servicing the US$111.2B global Metastatic Cancer market... Dec 31
CNS Pharma will initiate its trial during the first quarter of 2021 to investigate the efficacy of Berubicin in adults with GBM who have failed ... Dec 18
Latest FDA News Nov 26, 2020... Nov 26
-Advertisements-